486 related articles for article (PubMed ID: 23693133)
1. Factors affecting subjective memory complaints in the AIBL aging study: biomarkers, memory, affect, and age.
Buckley R; Saling MM; Ames D; Rowe CC; Lautenschlager NT; Macaulay SL; Martins RN; Masters CL; O'Meara T; Savage G; Szoeke C; Villemagne VL; Ellis KA;
Int Psychogeriatr; 2013 Aug; 25(8):1307-15. PubMed ID: 23693133
[TBL] [Abstract][Full Text] [Related]
2. Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL).
Ellis KA; Szoeke C; Bush AI; Darby D; Graham PL; Lautenschlager NT; Macaulay SL; Martins RN; Maruff P; Masters CL; McBride SJ; Pike KE; Rainey-Smith SR; Rembach A; Robertson J; Rowe CC; Savage G; Villemagne VL; Woodward M; Wilson W; Zhang P; Ames D;
Int Psychogeriatr; 2014 Apr; 26(4):543-54. PubMed ID: 24252258
[TBL] [Abstract][Full Text] [Related]
3. Personal memory function in mild cognitive impairment and subjective memory complaints: results from the Australian Imaging, Biomarkers, and Lifestyle (AIBL) Study of Ageing.
Buckley RF; Saling MM; Irish M; Ames D; Rowe CC; Lautenschlager NT; Maruff P; Macaulay SL; Martins RN; Masters CL; Rainey-Smith SR; Rembach A; Savage G; Szoeke C; Ellis KA
J Alzheimers Dis; 2014; 40(3):551-61. PubMed ID: 24496075
[TBL] [Abstract][Full Text] [Related]
4. Subjective memory complaints, depressive symptoms and instrumental activities of daily living in mild cognitive impairment.
Ryu SY; Lee SB; Kim TW; Lee TJ
Int Psychogeriatr; 2016 Mar; 28(3):487-94. PubMed ID: 26555226
[TBL] [Abstract][Full Text] [Related]
5. Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.
Lim YY; Ellis KA; Harrington K; Ames D; Martins RN; Masters CL; Rowe C; Savage G; Szoeke C; Darby D; Maruff P; The Aibl Research Group
J Clin Exp Neuropsychol; 2012; 34(4):345-58. PubMed ID: 22248010
[TBL] [Abstract][Full Text] [Related]
6. Phenomenological characterization of memory complaints in preclinical and prodromal Alzheimer's disease.
Buckley RF; Ellis KA; Ames D; Rowe CC; Lautenschlager NT; Maruff P; Villemagne VL; Macaulay SL; Szoeke C; Martins RN; Masters CL; Savage G; Rainey-Smith SR; Rembach A; Saling MM;
Neuropsychology; 2015 Jul; 29(4):571-81. PubMed ID: 25664464
[TBL] [Abstract][Full Text] [Related]
7. Predicting Alzheimer disease with β-amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageing.
Rowe CC; Bourgeat P; Ellis KA; Brown B; Lim YY; Mulligan R; Jones G; Maruff P; Woodward M; Price R; Robins P; Tochon-Danguy H; O'Keefe G; Pike KE; Yates P; Szoeke C; Salvado O; Macaulay SL; O'Meara T; Head R; Cobiac L; Savage G; Martins R; Masters CL; Ames D; Villemagne VL
Ann Neurol; 2013 Dec; 74(6):905-13. PubMed ID: 24448836
[TBL] [Abstract][Full Text] [Related]
8. Subjective memory complaints predict baseline but not future cognitive function over three years: results from the Western Australia Memory Study.
Sohrabi HR; Weinborn M; Laske C; Bates KA; Christensen D; Taddei K; Rainey-Smith SR; Brown BM; Gardener SL; Laws SM; Martins G; Burnham SC; Bucks RS; Reisberg B; Lautenschlager NT; Foster J; Martins RN
Int Psychogeriatr; 2019 Apr; 31(4):513-525. PubMed ID: 30277188
[TBL] [Abstract][Full Text] [Related]
9. Amyloid-β related memory decline is not associated with subjective or informant rated cognitive impairment in healthy adults.
Hollands S; Lim YY; Buckley R; Pietrzak RH; Snyder PJ; Ames D; Ellis KA; Harrington K; Lautenschlager N; Martins RN; Masters CL; Villemagne VL; Rowe CC; Maruff P
J Alzheimers Dis; 2015; 43(2):677-86. PubMed ID: 25114076
[TBL] [Abstract][Full Text] [Related]
10. The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease.
Ellis KA; Bush AI; Darby D; De Fazio D; Foster J; Hudson P; Lautenschlager NT; Lenzo N; Martins RN; Maruff P; Masters C; Milner A; Pike K; Rowe C; Savage G; Szoeke C; Taddei K; Villemagne V; Woodward M; Ames D;
Int Psychogeriatr; 2009 Aug; 21(4):672-87. PubMed ID: 19470201
[TBL] [Abstract][Full Text] [Related]
11. Self and informant memory concerns align in healthy memory complainers and in early stages of mild cognitive impairment but separate with increasing cognitive impairment.
Buckley R; Saling M; Ellis K; Rowe C; Maruff P; Macaulay LS; Martins R; Masters C; Savage G; Rainey-Smith S; Rembach A; Ames D
Age Ageing; 2015 Nov; 44(6):1012-9. PubMed ID: 26452663
[TBL] [Abstract][Full Text] [Related]
12. Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study.
Foster JK; Albrecht MA; Savage G; Lautenschlager NT; Ellis KA; Maruff P; Szoeke C; Taddei K; Martins R; Masters CL; Ames D;
Brain; 2013 Jul; 136(Pt 7):2201-16. PubMed ID: 23737466
[TBL] [Abstract][Full Text] [Related]
13. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging.
Rowe CC; Ellis KA; Rimajova M; Bourgeat P; Pike KE; Jones G; Fripp J; Tochon-Danguy H; Morandeau L; O'Keefe G; Price R; Raniga P; Robins P; Acosta O; Lenzo N; Szoeke C; Salvado O; Head R; Martins R; Masters CL; Ames D; Villemagne VL
Neurobiol Aging; 2010 Aug; 31(8):1275-83. PubMed ID: 20472326
[TBL] [Abstract][Full Text] [Related]
14. Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer's disease.
Julayanont P; Brousseau M; Chertkow H; Phillips N; Nasreddine ZS
J Am Geriatr Soc; 2014 Apr; 62(4):679-84. PubMed ID: 24635004
[TBL] [Abstract][Full Text] [Related]
15. Influence of population versus convenience sampling on sample characteristics in studies of cognitive aging.
Brodaty H; Mothakunnel A; de Vel-Palumbo M; Ames D; Ellis KA; Reppermund S; Kochan NA; Savage G; Trollor JN; Crawford J; Sachdev PS
Ann Epidemiol; 2014 Jan; 24(1):63-71. PubMed ID: 24211070
[TBL] [Abstract][Full Text] [Related]
16. Association of subjective memory complaint and depressive symptoms with objective cognitive functions in prodromal Alzheimer's disease including pre-mild cognitive impairment.
Seo EH; Kim H; Choi KY; Lee KH; Choo IH
J Affect Disord; 2017 Aug; 217():24-28. PubMed ID: 28380342
[TBL] [Abstract][Full Text] [Related]
17. Characterizing Aging, Mild Cognitive Impairment, and Dementia with Blood-Based Biomarkers and Neuropsychology.
Kleinschmidt M; Schoenfeld R; Göttlich C; Bittner D; Metzner JE; Leplow B; Demuth HU
J Alzheimers Dis; 2016; 50(1):111-26. PubMed ID: 26639953
[TBL] [Abstract][Full Text] [Related]
18. [Subjective memory complaints (SMC)].
Miyagawa T; Iwata A
Nihon Rinsho; 2016 Mar; 74(3):451-4. PubMed ID: 27025085
[TBL] [Abstract][Full Text] [Related]
19. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.
Egli SC; Hirni DI; Taylor KI; Berres M; Regeniter A; Gass A; Monsch AU; Sollberger M
J Alzheimers Dis; 2015; 44(2):625-33. PubMed ID: 25322924
[TBL] [Abstract][Full Text] [Related]
20. Regional Hippocampal Atrophy and Higher Levels of Plasma Amyloid-Beta Are Associated With Subjective Memory Complaints in Nondemented Elderly Subjects.
Cantero JL; Iglesias JE; Van Leemput K; Atienza M
J Gerontol A Biol Sci Med Sci; 2016 Sep; 71(9):1210-5. PubMed ID: 26946100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
